Your browser doesn't support javascript.
loading
Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells.
Ding, Siyuan; Zhu, Shu; Ren, Lili; Feng, Ningguo; Song, Yanhua; Ge, Xiaomei; Li, Bin; Flavell, Richard A; Greenberg, Harry B.
Afiliação
  • Ding S; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Stanford, United States.
  • Zhu S; Department of Microbiology and Immunology, Stanford University, Stanford, United States.
  • Ren L; Palo Alto Veterans Institute of Research, VA Palo Alto Health Care System, Palo Alto, United States.
  • Feng N; Institute of Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.
  • Song Y; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Stanford, United States.
  • Ge X; Department of Microbiology and Immunology, Stanford University, Stanford, United States.
  • Li B; Palo Alto Veterans Institute of Research, VA Palo Alto Health Care System, Palo Alto, United States.
  • Flavell RA; School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China.
  • Greenberg HB; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Stanford, United States.
Elife ; 72018 11 21.
Article em En | MEDLINE | ID: mdl-30460894
ABSTRACT
Rotaviruses (RVs), a leading cause of severe diarrhea in young children and many mammalian species, have evolved multiple strategies to counteract the host innate immunity, specifically interferon (IFN) signaling through RV non-structural protein 1 (NSP1). However, whether RV structural components also subvert antiviral response remains under-studied. Here, we found that MAVS, critical for the host RNA sensing pathway upstream of IFN induction, is degraded by the RV RNA methyl- and guanylyl-transferase (VP3) in a host-range-restricted manner. Mechanistically, VP3 localizes to the mitochondria and mediates the phosphorylation of a previously unidentified SPLTSS motif within the MAVS proline-rich region, leading to its proteasomal degradation and blockade of IFN-λ production in RV-infected intestinal epithelial cells. Importantly, VP3 inhibition of MAVS activity contributes to enhanced RV replication and to viral pathogenesis in vivo. Collectively, our findings establish RV VP3 as a viral antagonist of MAVS function in mammals and uncover a novel pathogen-mediated inhibitory mechanism of MAVS signaling.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Interferons / Rotavirus / Proteínas do Capsídeo / Proteínas Adaptadoras de Transdução de Sinal / Interações Hospedeiro-Patógeno Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Interferons / Rotavirus / Proteínas do Capsídeo / Proteínas Adaptadoras de Transdução de Sinal / Interações Hospedeiro-Patógeno Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos